Single-agent ibrutinib versus real-world (RW) treatments for patients with previously untreated chronic lymphocytic leukemia (CLL): Adjusted comparison of RESONATE-2™ with the CLLEAR and Lyon-Sud RW databases Journal Article


Authors: Doubek, M.; Smolej, M. L.; Simkovic, M.; Panovska, A.; Urbanova, R.; Lysak, D.; Callet-Bauchu, E.; Bachy, E.; Baseggio, L.; Ferrant, E.; Diels, J.; Cabrieto, J.; Nielsen, L.; Salles, G.
Article Title: Single-agent ibrutinib versus real-world (RW) treatments for patients with previously untreated chronic lymphocytic leukemia (CLL): Adjusted comparison of RESONATE-2™ with the CLLEAR and Lyon-Sud RW databases
Journal Title: Blood
Volume: 138
Issue: Suppl. 1
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-23
Language: English
ACCESSION: WOS:000835740102151
DOI: 10.1182/blood-2021-147927
PROVIDER: wos
Notes: Meeting Abstract: 4679 -- Hybrid meeting, also took place online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gilles Andre Salles
    269 Salles